Robert J. Morgan
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
- Urology top 1%
- Urinary Bladder and Prostate Research
Papers in
- Oncology 47
- Cancer Treatment and Pharmacology 14
- PARP inhibition in cancer therapy 8
- Co-authors
- Iván Soltész (8 shared papers)James H. Doroshow (51 shared papers)David R. Gandara (12 shared papers)George Somlo (49 shared papers)Amit M. Oza (15 shared papers)Gini F. Fleming (15 shared papers)Lucille Leong (41 shared papers)D.P. Mikhailidis (11 shared papers)
- Journals
- Journal of Clinical Oncology (30 papers)Cancer Chemotherapy and Pharmacology (19 papers)Journal of the National Comprehensive Cancer Network (8 papers)Gynecologic Oncology (8 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Robert J. Morgan
193 papers receiving 6.0k citations
Robert J. Morgan's Hit Papers
Peers
Comparison fields: 5 of 159
- Reproductive Medicine 721
- Urology 340
- Oncology 1.4k
- Psychiatry and Mental health 661
- Cancer Research 509
Countries citing papers authored by Robert J. Morgan
This map shows the geographic impact of Robert J. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Morgan more than expected).
Fields of papers citing papers by Robert J. Morgan
This network shows the impact of papers produced by Robert J. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Morgan. The network helps show where Robert J. Morgan may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert J. Morgan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 203 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia Hit paper breakdown → | 2007 | 457 |
| 2 | 2014 | 350 | |
| 3 | 2008 | 272 | |
| 4 | 2008 | 207 | |
| 5 | 2006 | 176 | |
| 6 | 2012 | 171 | |
| 7 | 2008 | 144 | |
| 8 | 1999 | 131 | |
| 9 | 2008 | 127 | |
| 10 | 2008 | 106 | |
| 11 | 1995 | 98 | |
| 12 | 2001 | 87 | |
| 13 | 1984 | 86 | |
| 14 | 2009 | 85 | |
| 15 | 2009 | 84 | |
| 16 | 2000 | 82 | |
| 17 | 1987 | 78 | |
| 18 | 2016 | 78 | |
| 19 | 2010 | 77 | |
| 20 | 2010 | 71 |
About Robert J. Morgan
Robert J. Morgan is a scholar working on Oncology, Molecular Biology, Psychiatry and Mental health, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 203 papers that have together received 6.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (27 papers), Sexual function and dysfunction studies (17 papers), Cancer Treatment and Pharmacology (14 papers), Urinary Bladder and Prostate Research (12 papers), Hormonal and reproductive studies (10 papers), Breast Cancer Treatment Studies (8 papers), Lung Cancer Treatments and Mutations (8 papers) and PARP inhibition in cancer therapy (8 papers). The work is most often cited by research in Reproductive Medicine (721 citations), Urology (340 citations), Oncology (1.4k citations), Psychiatry and Mental health (661 citations) and Cancer Research (509 citations). Robert J. Morgan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Iván Soltész, James H. Doroshow, David R. Gandara, George Somlo, Amit M. Oza, Gini F. Fleming, Lucille Leong, D.P. Mikhailidis, Kim Margolin and Dean Lim. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Journal of the National Comprehensive Cancer Network, Gynecologic Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.